Gestrinone compared with mifepristone for emergency contraception: a randomized controlled trial.
Wu
Shangchun
S
From the National Research Institute For Family Planning, Beijing, People's Republic of China; the Qingdao Family Planning Research Institute, Qingdao, People's Republic of China; the UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Geneva, Switzerland; and the Department of Family Medicine, University of Illinois College of Medicine, Chicago, Illinois.
Dong
Jing
J
Cong
Jie
J
Wang
Cuiping
C
VonHertzen
Helena
H
Godfrey
Emily M
EM
D000021:Abortifacient Agents, Steroidal / Q000008:administration & dosage*; D044363:Contraception, Postcoital; D004311:Double-Blind Method; D005260:Female; D005867:Gestrinone / Q000008:administration & dosage*; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage*; D011247:Pregnancy; D016896:Treatment Outcome
D000021:Abortifacient Agents, Steroidal; D005867:Gestrinone; D015735:Mifepristone